Role of protein kinase C in BSA-AGE-mediated inducible nitric oxide synthase expression in RAW 264.7 macrophages
- 4 June 2003
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 66 (2), 203-212
- https://doi.org/10.1016/s0006-2952(03)00249-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Advanced glycosylation end products induce nitric oxide synthase expression in C6 glioma cells: Involvement of a p38 MAP kinase-dependent mechanismLife Sciences, 2001
- Arecoline Desensitizes Carbachol‐Stimulated Phosphatidylinositol Breakdown in Rat Brain CorticesJournal of Neurochemistry, 1998
- Reversion of Ras- and Phosphatidylcholine-hydrolyzing Phospholipase C-mediated Transformation of NIH 3T3 Cells by a Dominant Interfering Mutant of Protein Kinase C λ Is Accompanied by the Loss of Constitutive Nuclear Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase ActivityJournal of Biological Chemistry, 1997
- Effect of Advanced Glycosylation End Products on the Induction of Nitric Oxide Synthase in Murine MacrophagesBiochemical and Biophysical Research Communications, 1996
- The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitusNephrology Dialysis Transplantation, 1996
- Nitric Oxide: Pathophysiological MechanismsAnnual Review of Physiology, 1995
- Phosphatidylcholine breakdown and signal transductionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.JCI Insight, 1993
- Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathyKidney International, 1991
- Glycosylation Products as Toxic Mediators of Diabetic ComplicationsAnnual Review of Medicine, 1991